Proposed Simultaneous Asset Purchase and Spin-Out Re-Aligns the Business and Assets of Two Public Companies, Creating a Nasdaq-listed Company Structured to Optimize Shareholder Value NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — GoLogiq, Inc. (OTC:GOLQ) (“GoLogiq”), a U.S.-based global provider of fintech and consumer data analytics, has signed a definitive agreement (the “Agreement”) for a…

ZyVersa Therapeutics Developing Cholesterol Transport Mediator for Kidney Diseases ZyVersa Therapeutics’ Breakthrough Treatment for Glomerular Diseases Cholesterol Transport Mediator™ VAR 200 is currently in development by ZyVersa Therapeutics to target and reduce renal cholesterol and lipid accumulation that damages the kidneys’ filtration system in patients with glomerular diseases. These diseases include diabetic kidney disease, focal…

ISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with “Sectoral Trends” In a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual Circumstances After Recommending Removal of Chair Vallone in 2022, ISS Appears to Blindly Accept Vallone’s and MindMed’s Justifications for Poor Development Decisions, Destructive Financing, and……

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Luminar Technologies, Inc. (LAZR) Investors Time to Pay Attention! What’s going on with Luminar Technologies, Inc.? Hey there, fellow investor! Have you heard the latest news about Luminar Technologies, Inc. and the class action lawsuit filed on behalf of…